{"id":"W4408295760","doi":"10.3389/fonc.2025.1530391","title":"Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review","year":2025,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Palbociclib; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Clinical trial; Progression-free survival; Breast cancer; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007339483,0.001079967,0.008102007,0.007126785,0.0003614777,0.002602043,0.001452889,0.001542745,0.004567423],"category_scores_gemma":[0.03466962,0.0009033594,0.007476323,0.007101531,0.0005641117,0.002084251,0.001161191,0.001301383,0.0003404603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002935488,"about_ca_system_score_gemma":0.007402923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009597284,"about_ca_topic_score_gemma":0.03022482,"domain_scores_codex":[0.9952629,0.001586587,0.001841888,0.0003492676,0.0008049839,0.0001544747],"domain_scores_gemma":[0.9715455,0.02042336,0.00505723,0.0003263104,0.002429574,0.0002179854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0003272588,0.00001376767,0.0006247439,0.9446255,0.01608465,0.00006282643,0.00009726499,0.0001133855,0.0001407066,0.0001717462,0.002008639,0.03572958],"study_design_scores_gemma":[0.0005095046,0.000293865,0.005229745,0.7873595,0.1803167,0.0004059623,0.000197099,0.0001371801,0.0001799041,0.0003596139,0.02496366,0.00004727723],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006857128,0.9982666,0.00005959818,0.0002002896,0.00006711388,0.00008774721,0.0004112788,0.000005948453,0.0002157327],"genre_scores_gemma":[0.01323744,0.9851182,0.0003485698,0.0006206653,0.00007460218,0.0001739166,0.0003229979,0.000005937855,0.00009769512],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009597284,"threshold_uncertainty_score":0.03881532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02307810834817388,"score_gpt":0.3946680097727225,"score_spread":0.3715899014245486,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}